Abstract
Type I diabetes mellitus (TIDM) is a kind of chronic disease, which caused by autoimmune disorders which result in hyperglycemia and inadequate insulin secretion. Over the past 25 years, knowledge about T1DM has advanced rapidly. These recent progressions in researching T1DM help us better understand the disease in various aspects including genetics, epidemiology, immunology, and pancreatic cancer. Epidemiology, immunology, beta cell phenotype, and disease burden. Why is T1DM thought to be preventable? Several areas of diabetes research have been brought together to suggest therapeutic targets. This article introduces T1DM from its basic definition, world impact, pathology, current existing drug-assistant treatment, and now existing diagnostic tools such as OGTT. This article is based on literature across several fields including Medications, Epidemics, and Statistics. Also, several anti-diabetic drugs that have the potential in participating T1DM treatment as assistance were listed as well. For example, metformin has been recognized as having a huge potential in reducing blood sugar level company with insulin. This article mainly focused on showing information about T1DM and attempting to make several predictions on potential treatments that may be helpful for future patients.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
